Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DP13 in Primary Aldosteronism
NCT04007406Phase 2Completed
- Sponsor
- Damian Pharma AG
- Start
- Nov 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexfadrostat in primary aldosteronism (PA), sponsored by Damian Pharma AG. Started Nov 2019; status: completed.
02
Drugs
dexfadrostat
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT04007406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04007406.